Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease.

The American Journal of Tropical Medicine and Hygiene
M J LevinM B Rosenbaum

Abstract

To identify Trypanosoma cruzi target antigens in overt Chagas' heart disease, a parasite lambda gt11 cDNA library was screened with the serum of a patient with a severe chagasic heart involvement (JL). Using a phage dot array immunoassay, 5 highly antigenic clones, JL1, JL5, JL7, JL8, and JL9, were probed with sera from clinically characterized T. cruzi infected subjects. The correlation of cloned T. cruzi antigen recognition with the clinical status of the subjects led to the identification of a recombinant antigen, JL5, that reacted predominantly with sera from patients with Chagas' heart disease. The antigenic determinant of the JL5 recombinant was a small 35 amino acid peptide. The nucleotide and the deduced amino acid sequence, together with other experimental data, allowed identification as the C-terminal portion of a T. cruzi P ribosomal protein. The C-terminal undecapeptide in JL5, EDDDMGFGLFD, was highly homologous to the same region of the human P protein SD(D/E)DMGFGLFD. The latter sequence has been identified as the P protein epitope in systemic lupus erythematosus (SLE). Positive SLE sera reacted with the JL5 recombinant phage, suggesting that the T. cruzi P protein might induce antibodies with a similar specificit...Continue Reading

Citations

May 1, 1997·Applied Biochemistry and Biotechnology·Y M Gomes
Jun 10, 2000·Memórias do Instituto Oswaldo Cruz·E S Umezawa, J F Silveira
Nov 26, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vanina GrippoMariano J Levin
Sep 1, 1991·Clinical and Experimental Immunology·G LevitusM J Levin
Nov 1, 1992·Die Naturwissenschaften·R Felleisen, M Q Klinkert
Jun 8, 2001·Memórias do Instituto Oswaldo Cruz·Y M GomesS Goldenberg
Jan 1, 1997·Revista Do Instituto De Medicina Tropical De São Paulo·M de L Higuchi
Feb 4, 2006·Autoimmunity·Edecio Cunha-NetoDavid M Engman
Dec 23, 2003·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M C BosettoR M B Cicarelli
Jul 30, 2010·Clinical and Vaccine Immunology : CVI·Pilar HernándezEwald Beck
Dec 1, 1991·FEMS Microbiology Immunology·M J LevinR Rangel-Aldao
Nov 7, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M O MasudaA C Campos de Carvalho
Mar 1, 1995·São Paulo Medical Journal = Revista Paulista De Medicina·E Cunha-Neto, J Kalil
Aug 31, 2001·Clinical and Diagnostic Laboratory Immunology·M NakazawaY M Gomes
May 26, 2011·Expert Review of Anti-infective Therapy·Paulo M M GuedesJoão S Silva
Dec 1, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P López BergamiM J Levin
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·Simone GarciaMilena B P Soares
Aug 23, 2005·Memórias do Instituto Oswaldo Cruz·Gustavo C CerqueiraSantuza M R Teixeira
Mar 2, 2011·Infection and Immunity·Fredy R S GutierrezJoão S Silva
May 9, 2007·Infection and Immunity·Kenneth V HylandDavid M Engman
Jul 26, 2018·PLoS Neglected Tropical Diseases·Nathalie de Sena PereiraEgler Chiari
Jun 6, 2002·Memórias do Instituto Oswaldo Cruz·Simone Frédérique BrenièreMireille Hontebeyrie
Oct 15, 2009·Parasite Immunology·F R S GutierrezJ S Silva
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·M VazquezM J Levin
May 29, 2003·FEMS Immunology and Medical Microbiology·Felipe Kierszenbaum
Mar 9, 2021·Annals of the New York Academy of Sciences·Héctor O Rodríguez-AnguloNúria Gironès
May 1, 1997·FEMS Immunology and Medical Microbiology·C AznarM Hontebeyrie
Dec 1, 1995·FEMS Immunology and Medical Microbiology·C AznarD Kaplan
Oct 1, 1993·FEMS Immunology and Medical Microbiology·M J LevinA Panebra
Mar 18, 1999·Molecular and Biochemical Parasitology·M H Villas BôasE B Bergter
Apr 9, 1999·Clinical Microbiology Reviews·F Kierszenbaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.